On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Herantis Pharma Oyj's own share of each project, not the project's full budget.
- Horizon Europe€6.9M · 2 projects
- Horizon 2020€900k · 1 project
Projects
3 EU-funded projects, newest first. Herantis Pharma Oyj led 1 of them as coordinator. Each links to the official record.
- HERMODPartner
Phase IIa Double-Blind, Placebo- Controlled, Randomized, Efficacy and Safety Study of Subcutaneously Administered HER-096 in Patients with Early-Stage Parkinson’s Disease HERMOD
Horizon Europe · 2026–2030 · Project on CORDIS ↗
€4.4Mtheir share - ReTreatPDCoordinator
Revolutionary therapeutic treatment for stopping progression of Parkinson's disease
Horizon Europe · 2023–2025 · Project on CORDIS ↗
€2.5Mtheir share - TreatERPartner
Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
Horizon 2020 · 2017–2020 · Project on CORDIS ↗
€900ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Karolinska InstitutetSweden · 2 shared projects
- Region StockholmSweden · 2 shared projects
- Region SkaneSweden · 2 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 1 shared project
- Helsingin YliopistoFinland · 1 shared project
- Hus-YhtymaFinland · 1 shared project
- Luxembourg Institute of HealthLuxembourg · 1 shared project
- Renishaw PLCUnited Kingdom · 1 shared project
- H. Lundbeck ASDenmark · 1 shared project
- Renishaw Neuro Solutions LtdUnited Kingdom · 1 shared project
- Association Europeenne Pour la Maladie de ParkinsonBelgium · 1 shared project
- Orion OyjFinland · 1 shared project
- Renishaw (Ireland) LtdIreland · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- dementia
- drug discovery
- nuclear medicine
- parkinson
- pathology
- pharmaceutical drugs
- pharmacokinetics
- proteins
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.